Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319904 · ClinicalTrials.gov registry record
The Partners Genetics Collaborative Study of Schizophrenia
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 451
- Enrollment target
NCT00319904: Completed study, sponsored by Massachusetts General Hospital.
NCT00319904 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 451 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00319904 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 451 participants
- Enrollment target
Study Summary
We will collect DNA from 500 rigorously diagnosed patients with schizophrenia to allow us in the future to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimaging or pharmacologic challenges.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2001-03 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00319904
The ClinicalTrials.gov registry entry for NCT00319904 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 451 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00319904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00319904 about?
NCT00319904 is a clinical study titled "The Partners Genetics Collaborative Study of Schizophrenia". We will collect DNA from 500 rigorously diagnosed patients with schizophrenia to allow us in the future to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimagin...
What is the current status of trial NCT00319904?
This trial is currently completed. The enrollment target is 451 participants. The study started on 2001-03. Estimated completion is 2017-10.
Who is sponsoring clinical trial NCT00319904?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.